NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Receives Average Rating of “Moderate Buy” from Brokerages

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) has received an average rating of “Moderate Buy” from the five ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, three have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 12 month price target among analysts that have issued a report on the stock in the last year is $1.9833.

A number of brokerages have weighed in on NMTC. Wall Street Zen raised NeuroOne Medical Technologies to a “sell” rating in a research report on Saturday, February 21st. JonesTrading assumed coverage on shares of NeuroOne Medical Technologies in a research note on Monday, March 2nd. They set a “buy” rating and a $1.50 price objective on the stock. Finally, Zacks Research raised shares of NeuroOne Medical Technologies from a “hold” rating to a “strong-buy” rating in a research note on Monday, January 5th.

NeuroOne Medical Technologies Price Performance

NMTC stock opened at $0.84 on Monday. The company has a market capitalization of $42.45 million, a PE ratio of -4.94 and a beta of 0.74. NeuroOne Medical Technologies has a 12 month low of $0.40 and a 12 month high of $1.16. The firm’s 50-day moving average is $0.81 and its 200 day moving average is $0.79.

NeuroOne Medical Technologies (NASDAQ:NMTC) last released its quarterly earnings data on Tuesday, February 17th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.01. The company had revenue of $2.89 million during the quarter, compared to analysts’ expectations of $2.47 million. NeuroOne Medical Technologies had a negative net margin of 78.34% and a negative return on equity of 119.92%.

Insider Activity

In other NeuroOne Medical Technologies news, insider David J. Wambeke acquired 1,000,000 shares of the stock in a transaction dated Sunday, March 1st. The stock was purchased at an average price of $0.67 per share, with a total value of $670,000.00. Following the transaction, the insider directly owned 1,000,000 shares of the company’s stock, valued at $670,000. This trade represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 8.90% of the company’s stock.

Institutional Trading of NeuroOne Medical Technologies

Several large investors have recently bought and sold shares of the stock. Focus Financial Network Inc. purchased a new stake in shares of NeuroOne Medical Technologies during the third quarter valued at $31,000. Warberg Asset Management LLC acquired a new stake in shares of NeuroOne Medical Technologies during the second quarter worth about $27,000. Legato Capital Management LLC purchased a new position in NeuroOne Medical Technologies during the 4th quarter worth approximately $34,000. Squarepoint Ops LLC purchased a new stake in shares of NeuroOne Medical Technologies in the 4th quarter valued at $36,000. Finally, Susquehanna International Group LLP acquired a new stake in shares of NeuroOne Medical Technologies in the third quarter worth $47,000. Hedge funds and other institutional investors own 16.07% of the company’s stock.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies Corp. is a medical device company focused on developing advanced neural interface technologies for diagnostic and therapeutic applications in neurosurgery and neurology. The company’s core mission is to improve patient outcomes through next-generation electrode systems that enable high-resolution neural recording and targeted stimulation. By leveraging proprietary thin-film microelectrode arrays, NeuroOne aims to offer clinicians unprecedented single-unit precision during brain mapping procedures.

The company’s flagship platform, the EVO™ system, integrates thin-film neural electrodes with intraoperative monitoring hardware and software.